Selectis Health, INC 8-K filings

Selectis Health, Inc. announced the resignation of CEO and CFO Adam Desmond, appointing Krystal Eckhart as interim CEO and CFO.

Selectis Health, Inc. has finalized the sale of two skilled nursing facilities in Georgia for $15.7 million.

David Furstenberg has resigned from Selectis Health, Inc.'s Board of Directors and Audit Committee, effective March 30, 2026.

Selectis Health, Inc. announced the sale of two skilled nursing facilities in Georgia for $13.175 million, aiming to reduce debt and bolster working capital.

Selectis Health, Inc. announced the appointment of Kent J. Lund and Lance Baller to its Board of Directors, effective January 1, 2026, bringing extensive legal, financial, and corporate governance expertise.

Selectis Health, Inc. has modified its 2018 Senior Secured Promissory Notes, extending the maturity date to February 28, 2026, increasing the interest rate to 13%, and appointing two new board members.

Selectis Health, Inc. announced the sale of its Sparta and Warrenton skilled nursing facilities in Georgia for $13.175 million, contingent on due diligence and other conditions.

Selectis Health, Inc. announced that the Purchaser has terminated the Purchase and Sale Agreement and Operations Transfer Agreement for the sale of its Georgia subsidiaries.

Selectis Health, Inc. announced that its common stock has been approved for upgraded quotation on the OTCQB, effective with the market open on Monday, June 23, 2025.

Selectis Health's subsidiaries have agreed to sell four skilled nursing facilities in Georgia for an aggregate purchase price of $27 million, subject to customary adjustments and conditions.

James Creamer resigned as CFO of Selectis Health, effective January 17, 2025, with CEO Adam Desmond stepping in as Interim CFO.

Selectis Health has appointed WithumSmith+Brown as its new independent registered public accounting firm, effective December 4, 2024.

Selectis Health has terminated its relationship with its independent auditor, Marcum LLP, effective November 20, 2024, and has not yet engaged a new auditor.

Selectis Health's CEO, Adam Desmond, received a salary increase to $250,000 per annum, while forgoing his quarterly board compensation stipend.

Selectis Health has appointed James Creamer as its new Chief Financial Officer, effective August 15, 2024.

Andrew Sink resigned from the Selectis Health Board of Directors effective June 30, 2024, and the company has no immediate plans to fill the vacancy.

Selectis Health has finalized the sale of its Archway Transitional Care Center property in Macon, Georgia, for $6.75 million.

Selectis Health has agreed to sell its Archway Transitional Care Center in Georgia for $6.75 million, aiming to strengthen its balance sheet and optimize its remaining facilities.

Selectis Health, through its subsidiary, has entered into an agreement to sell the Archway Transitional Care Center in Macon, Georgia for $6.75 million.

Selectis Health, Inc. has entered into a Commercial Line of Credit Agreement with Southern Bank for a $750,000 line of credit at a fixed interest rate of 8.50% per annum.

Selectis Health has appointed Adam Desmond as its permanent Chief Executive Officer, effective March 18, 2024.

Selectis Health, Inc. has approved a form of Indemnity Agreement for its officers and directors, effective March 18, 2024.

Selectis Health's agreement to sell certain Georgia subsidiaries has been terminated by the purchaser, who cited alleged defaults, which Selectis denies.